Company News

Share this article:

Aventis Pharmaceutical, a subsidiary of Sanofi-Aventis, will pay $95.5 million to settle Department of Justice allegations that it violated the False Claims Act by misreporting drug prices to reduce its Medicaid Drug Rebate obligations. The allegations refer to pricing on Azmacort, Nasacort and Nasacort AQ, between 1995 and 2000.

 

WeissComm Group announced the acquisition of Common Sense Media Group, a social media consulting company founded by Bob Pearson, who will become WeissComm's chief technology and media officer. WeissComm also signed a strategic alliance with Rule 13, a firm focused on social media education, research and training.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.